Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
2(20%)
Results Posted
100%(2 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_2
2
20%
Ph phase_4
3
30%
Ph phase_1
1
10%
Ph phase_3
3
30%

Phase Distribution

1

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(2)
Terminated(3)
Other(1)

Detailed Status

Recruiting2
Terminated2
Completed2
Not yet recruiting1
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 22 (20.0%)
Phase 33 (30.0%)
Phase 43 (30.0%)
N/A1 (10.0%)

Trials by Status

not_yet_recruiting110%
recruiting220%
enrolling_by_invitation110%
terminated220%
completed220%
unknown110%
withdrawn110%

Recent Activity

2 active trials
Showing 5 of 10
enrolling_by_invitationphase_2

Neuroimaging of Escitalopram in Autism Spectrum Disorder

NCT06826326
recruitingphase_2

Escitalopram and Language Intervention for Subacute Aphasia

NCT03843463
not_yet_recruitingphase_1

Effort and Antidepressant Study Test

NCT06696482
recruitingnot_applicable

Effect of Electroacupuncture on Treating the First-episode Depression

NCT05818735
unknownphase_3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

NCT06025474
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06826326Phase 2

Neuroimaging of Escitalopram in Autism Spectrum Disorder

Enrolling By Invitation
NCT03843463Phase 2

Escitalopram and Language Intervention for Subacute Aphasia

Recruiting
NCT06696482Phase 1

Effort and Antidepressant Study Test

Not Yet Recruiting
NCT05818735Not Applicable

Effect of Electroacupuncture on Treating the First-episode Depression

Recruiting
NCT06025474Phase 3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

Unknown
NCT05480878Phase 3

Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis

Completed
NCT02532660Phase 3

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode

Terminated
NCT03464383Phase 4

Anxiety and Depression in Epilepsy: A Treatment Study

Completed
NCT03522987Phase 4

Anxiety and Depression in Epilepsy: A Pilot Treatment Study

Withdrawn
NCT01787240Phase 4

Neurobiological Bases of Placebo Response in Major Depressive Disorder

Terminated

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10